Connecting you to content on EBSCOhost

Works matching IS 1025496X AND DT 2024 AND VI 29 AND IP 50

Results: 5

1

Direct and indirect effects of the COVID-19 pandemic on mortality: an individual-level population-scale analysis using linked electronic health records, Wales, United Kingdom, 2016 to 2022.

Published in:

Eurosurveillance (15607917), 2024, v. 29, n. 50, p. 1, doi. 10.2807/1560-7917.ES.2024.29.50.2400085

By:

Owen, Rhiannon K.;
van Oppen, James D.;
Lyons, Jane;
Akbari, Ashley;
Davies, Gareth;
Torabi, Fatemeh;
Abrams, Keith R.;
Lyons, Ronan A.

Publication type:

Article

2

Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024.

Published in:

Eurosurveillance (15607917), 2024, v. 29, n. 50, p. 1, doi. 10.2807/1560-7917.ES.2024.29.50.2400074

By:

Ploin, Dominique;
Alexandre, Mathilde;
Ventelou, Bruno;
Che, Didier;
Coignard, Bruno;
Boulanger, Nathalie;
Burucoa, Christophe;
Caron, François;
Gallian, Pierre;
Hansmann, Yves;
Lienhardt, Christian;
Minodier, Philippe;
Partouche, Henri;
Revest, Matthieu;
Saidani, Nadia;
Salvat, Gilles;
Vignier, Nicolas;
Floreani, Sylvie;
Henry, Sabine;
Pozzetto, Bruno

Publication type:

Article

3

Nuvaxovid NVX-CoV2373 vaccine safety profile: real-world data evidence after 100,000 doses, Australia, 2022 to 2023.

Published in:

Eurosurveillance (15607917), 2024, v. 29, n. 50, p. 1, doi. 10.2807/1560-7917.ES.2024.29.50.2400164

By:

Clothier, Hazel J.;
Parker, Claire;
Mallard, John H.;
Effler, Paul;
Bloomfield, Lauren;
Carcione, Dale;
Buttery, Jim P.

Publication type:

Article

4

Antigenic changes in influenza A(H3N2) driven by genetic evolution: Insights from virological surveillance, EU/EEA, week 40/2023 to week 9/2024.

Published in:

Eurosurveillance (15607917), 2024, v. 29, n. 50, p. 1, doi. 10.2807/1560-7917.ES.2024.29.50.2400395

By:

Broberg, Eeva K.;
Vukovikj, Maja;
Svartström, Olov;
Hasibra, Iris;
Riess, Maximilian;
Melidou, Angeliki

Publication type:

Article

5

An outbreak of influenza A(H1N1)pdm09 antigenic variants exhibiting cross-resistance to oseltamivir and peramivir in an elementary school in Japan, September 2024.

Published in:

Eurosurveillance (15607917), 2024, v. 29, n. 50, p. 1, doi. 10.2807/1560-7917.ES.2024.29.50.2400786

By:

Emi Takashita;
Kohei Shimizu;
Shuzo Usuku;
Ryuichi Senda;
Ichiro Okubo;
Hiroko Morita;
Shiho Nagata;
Seiichiro Fujisaki;
Hideka Miura;
Noriko Kishida;
Kazuya Nakamura;
Masayuki Shirakura;
Masataka Ichikawa;
Yoko Matsuzaki;
Shinji Watanabe;
Yoshimasa Takahashi;
Hideki Hasegawa

Publication type:

Article